QVT Financial, started by ex-Deutsche Bank prop traders, is among the largest shareholders of Inhibitex, which agreed over the weekend to a $2.5 billion acquisition by Bristol-Myers Squibb. According to regulatory filings, QVT first bought shares for about $1 each in 2009, and also took warrants to acquire millions more shares at $1.46 each. That means QVT's stock is worth about $105 million at Bristol-Myers's takeover price, or very roughly 25 times what QVT paid for its investment in 2009. Now the slightly bad news: QVT missed out on an even bigger windfall because it sold a block of Inhibitex last fall, just months before the company's sale. Jim Rogers, George Soros, And Warren Buffett Are All Bullish About Euro Assets ( Insider Monkey ) Jim Rogers, George Soros, and Warren Buffett are doing the same thing together –bargain-hunting euro assets. Jim Rogers said publicly on Tuesday last week that the euro and Swiss franc will show buying opportunities in 2012.